Target
Cyclin-dependent kinase 2
Ligand
BDBM444604
Substrate
n/a
Meas. Tech.
LANCE Ultra ULight Assay
IC50
358±n/a nM
Citation
 Xia, GWang, QShi, CZhai, XGe, HLiao, XMao, YXiang, ZHan, YHuo, GLiu, Y Substituted pyrimidines as cyclin-dependent kinase inhibitors US Patent  US10662186 Publication Date 5/26/2020 
Target
Name:
Cyclin-dependent kinase 2
Synonyms:
CDK2 | CDK2-Kinase | CDK2_HUMAN | CDKN2 | Cell division protein kinase 2 | Cyclin-dependent kinase 2 (CDK2) | Protein cereblon/Cyclin-dependent kinase 2 | p33 protein kinase
Type:
Enzyme Subunit
Mol. Mass.:
33938.17
Organism:
Homo sapiens (Human)
Description:
P24941
Residue:
298
Sequence:
MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL
  
Inhibitor
Name:
BDBM444604
Synonyms:
US10662186, Compound 140 | US10988476, Compound I-140
Type:
Small organic molecule
Emp. Form.:
C26H30F2N8
Mol. Mass.:
492.5668
SMILES:
CCn1c(C)nc2c(F)cc(cc12)-c1nc(Nc2ccc3CN(CCN(C)C)CCc3n2)ncc1F
Structure:
Search PDB for entries with ligand similarity: